Medicine
Medroxyprogesterone 10 mg tablet
Medroxyprogesterone 10 mg tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Medroxyprogesterone
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 1 bottle and 30 more
- Manufacturers
- Bryant Ranch PrepackProficient RxPD-Rx PharmaceuticalsA-S Medication SolutionsMylan PharmaceuticalsNuCare Pharmaceuticals,IncPharmPakPreferred PharmaceuticalsTeva PharmaceuticalsAmerican Health Packaging
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03AC06 Medroxyprogesterone
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 June 1959
- Identifiers
- RxCUI 1000114, 1000135, 1000141DailyMed set ID 816b9fd2-bc55-496b-846a-cabe7bbdecd6, 5c8ffae3-3b3e-197e-e053-2a91aa0a59e3, 0de6142f-a78e-ae58-e063-6394a90adff0 +10NDC 50090-0166, 68071-4132, 51655-520 +10Application ANDA040159, NDA011839
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59762-0056-1 | Mylan Pharmaceuticals | 17 June 2019 |
| 1000 tablet in 1 bottle | 59762-0056-2 | Mylan Pharmaceuticals | 23 March 2020 |
| 1 bottle in 1 box / 5 tablet in 1 bottle | 54348-805-05 | PharmPak | 12 July 2019 |
| 1 bottle in 1 box / 10 tablet in 1 bottle | 54348-805-10 | PharmPak | 12 July 2019 |
| 100 tablet in 1 bottle | 0555-0779-02 | Teva Pharmaceuticals | 4 December 1996 |
| 500 tablet in 1 bottle | 0555-0779-04 | Teva Pharmaceuticals | 4 December 1996 |
| 10 tablet in 1 bottle | 63629-2612-1 | Bryant Ranch Prepack | 13 June 2011 |
| 30 tablet in 1 bottle | 63629-2612-2 | Bryant Ranch Prepack | 17 August 2007 |
| 5 tablet in 1 bottle | 63629-2612-3 | Bryant Ranch Prepack | 12 August 2011 |
| 60 tablet in 1 bottle | 63629-2612-4 | Bryant Ranch Prepack | 14 June 2016 |
| 90 tablet in 1 bottle | 63629-2612-5 | Bryant Ranch Prepack | 28 July 2021 |
| 20 tablet in 1 bottle | 63629-2612-6 | Bryant Ranch Prepack | 8 July 2024 |
| 100 tablet in 1 bottle | 63629-2612-7 | Bryant Ranch Prepack | 9 October 2017 |
| 100 tablet in 1 bottle | 63629-8824-1 | Bryant Ranch Prepack | 4 December 1996 |
| 10 tablet in 1 bottle | 50090-0166-0 | A-S Medication Solutions | 21 June 2016 |
| 30 tablet in 1 bottle | 50090-0166-2 | A-S Medication Solutions | 28 November 2014 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 60687-105-21 | American Health Packaging | 19 April 2016 |
| 30 tablet in 1 bottle, plastic | 51655-520-52 | Northwind Health | 27 December 2023 |
| 10 tablet in 1 bottle | 68071-4132-1 | NuCare Pharmaceuticals,Inc | 27 October 2017 |
| 30 tablet in 1 bottle | 68071-4132-3 | NuCare Pharmaceuticals,Inc | 27 October 2017 |
| 5 tablet in 1 bottle, plastic | 55289-160-05 | PD-Rx Pharmaceuticals | 18 January 2011 |
| 10 tablet in 1 bottle, plastic | 55289-160-10 | PD-Rx Pharmaceuticals | 18 January 2011 |
| 30 tablet in 1 bottle, plastic | 55289-160-30 | PD-Rx Pharmaceuticals | 18 January 2011 |
| 50 tablet in 1 bottle, plastic | 55289-160-50 | PD-Rx Pharmaceuticals | 18 January 2011 |
| 10 tablet in 1 bottle | 68788-9899-1 | Preferred Pharmaceuticals | 13 February 2012 |
| 30 tablet in 1 bottle | 68788-9899-3 | Preferred Pharmaceuticals | 13 February 2012 |
| 10 tablet in 1 bottle | 63187-382-10 | Proficient Rx | 1 February 2019 |
| 20 tablet in 1 bottle | 63187-382-20 | Proficient Rx | 1 September 2016 |
| 30 tablet in 1 bottle | 63187-382-30 | Proficient Rx | 1 September 2016 |
| 40 tablet in 1 bottle | 63187-382-40 | Proficient Rx | 1 September 2016 |
| 60 tablet in 1 bottle | 63187-382-60 | Proficient Rx | 1 September 2016 |
| 90 tablet in 1 bottle | 63187-382-90 | Proficient Rx | 1 September 2016 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-3070-2 | Remedyrepack | 20 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 June 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Medroxyprogesterone 10 mg tablet.
Other strengths and forms of Medroxyprogesterone
Clinical summary
Medroxyprogesterone is a progestin indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. MedsAcross supplies Medroxyprogesterone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MedroxyprogesteroneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Provera prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Medroxyprogesterone 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.